ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 658450 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 658450; 2) Community: the network communities that were significantly associated with the response to NSC 658450; 3) Molecule: the relationships between components within communities and NSC 658450; 4) MDR: the compounds that were significantly associated with the NSC 658450.

NSC Compound Enrichment Correlation
NSC 718809 Null 0.0208632511155816 -0.28728718
NSC 758664 Sirolimus [USAN] 0.0208632511155816 -0.20277674
NSC 109451 Null 0.0208632511155817 -0.25409699
NSC 117915 1H-Indole-2,3-dione, 5-methyl-,3-[2-(2-nitrophenyl)hydrazone] 0.0208632511155817 -0.33976232
NSC 150311 2-Propenone, 1-(4-bromophenyl)-2-(4-morpholinylmethyl)-3-phenyl-, hydrobromide, (Z)- 0.0208632511155817 0.4749524
NSC 155693 6H-Pyrido[4,3-b]carbazolium, 9-methoxy-2,5,11-trimethyl-,iodide 0.0208632511155817 -0.20211513
NSC 295501 Camptothecin Derivative 0.0208632511155817 0.086690337
NSC 309401 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride 0.0208632511155817 0.43014362
NSC 319440 Null 0.0208632511155817 -0.27611156
NSC 320877 Geldanamycin, 17-[(2-chloroethyl)amino]-17-demethoxy- 0.0208632511155817 0.45167503
Total:76  Current:36    [First] [Prev] [Next] [Last]